Filing Details
- Accession Number:
- 0000899243-16-028840
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-12 21:52:33
- Reporting Period:
- 2016-09-08
- Filing Date:
- 2016-09-12
- Accepted Time:
- 2016-09-12 21:52:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-08 | 31,269 | $10.29 | 648,307 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-08 | 31,269 | $50.08 | 638,835 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-09-10 | 6,148 | $0.00 | 0 | No | 5 | G | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 5 | G | Indirect | by Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2016-09-08 | 31,269 | $0.00 | 31,269 | $10.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 115,443 | 2017-08-28 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $50.00 to $50.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- The Reporting Person previously contributed shares of SGEN common stock to a grantor retained annuity trust for the benefit of himself and trusts for his children. Upon the termination of the trust on September 10, 2016, 6,148 of the shares were transferred to the Reporting Person's children's trusts and the remaining 21,797 shares were transferred to the Reporting Person and are included in the reported number of shares directly owned by the Reporting Person.
- Shares vested at a rate of 25% on 8/28/08 and monthly thereafter until all the shares were fully vested on 8/28/11.
Billionaire Hedge Funds
